Cover Image
市場調查報告書

中國的血液疾病治療藥市場

Blood Disease Drugs Markets in China

出版商 Asia Market Information & Development 商品編碼 91227
出版日期 內容資訊 英文 290 Pages
訂單完成後即時交付
價格
Back to Top
中國的血液疾病治療藥市場 Blood Disease Drugs Markets in China
出版日期: 2016年05月01日 內容資訊: 英文 290 Pages
簡介

中國的血液疾病治療藥需求在過去十年急速擴大,預計今後5年該需求也將隨著生產增加一同成長。

本報告提供中國的經濟趨勢,血液疾病治療藥市場投資環境,產業的發展,需求及供給,產業結構,市場流通管道及主要企業等相關的詳細調查,實際成果,長期預測,為您概述為以下內容。

第1章 簡介

  • 本調查書的範圍和方法論
  • 摘要整理

第2章 商務環境

  • 經濟展望
    • 主要的經濟指標
    • 工業生產量
    • 人口及人力資源
    • 來自海外的投資
    • 海外貿易
  • 金融及稅金的法規
    • 銀行制度及法規
    • 外匯
    • 稅金,關稅及海關

第3章 血液疾病治療藥產業的評估

  • 產業結構
  • 市場規模
  • 推動市場成長要素
  • 銷售量
  • 主要製造商的設備據點及銷售量
  • 主要製造廠商的市場佔有率
  • 勞動成本
  • 有潛在性的參與企業
  • 主要的經銷商
  • 主要的海外投資
  • 技術開發

第4章 血液疾病治療藥的生產及需求

  • 概要
  • 各地區需求
  • 血液疾病治療藥的銷售量
    • 貧血症
    • 嗜中性白血球低下症及粒球減少症
    • 白血病
    • 其他
  • 血液疾病治療藥的進口
  • 價格趨勢

第5章 血液疾病治療藥市場展望

  • 血液疾病治療藥市場展望
  • 政府的法規
  • 健康保險產業概要
  • 消費者支出趨勢
  • 人口動態
  • 醫療產業趨勢
  • 醫院及病床
  • 醫生及出診

第6章 行銷策略

  • 中國市場進入概要
    • 中國流通系統
    • 血液疾病治療藥的流通管道
    • 運輸及運輸基礎設施
    • 通訊
  • 中國市場進入
    • 對中國出口
    • 間接出口
    • 直接出口
    • 專利及聯盟製造
    • 中國內的組裝
    • 聯盟製造
    • 貿易許可
    • 投資
    • 資本聯盟
    • 合併企業
    • 完全外資企業

第7章 血液疾病治療藥製造商目錄

  • 製造商簡介
  • 經銷商及貿易公司
  • 研究機關及協會

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 805

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

ULIST OF CHARTS

I. NTRODUCTION

  • Blood Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Blood Disease Drugs Sales Volume
  • Worldwide Blood Disease Drugs Demand by region
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Mecobalamin Sales Volume and Market Share
  • Cobamamide Sales Volume and Market Share
  • Ferrous Succinate Sales Volume and Market Share
  • Leucogen Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Sales Volume and Market Share
  • Batilol Sales Volume and Market Share
  • Inosine Sales Volume and Market Share
  • Deoxyribonucleotide Sales Volume and Market Share
  • Adrenocortical Hormone Sales Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Sales Volume and Market Share
  • Imatinib Mesylate Sales Volume and Market Share
  • Rituximab Sales Volume and Market Share
  • Pirarubicin Sales Volume and Market Share
  • Hydroxycampothecin Sales Volume and Market Share
  • Other Blood Disease Drugs Sales volume and Market Share
  • Blood Disease Drugs Import Volume
  • Anemia Import Volume and Market Share
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Mecobalamin Import Volume and Market Share
  • Cobamamide Import Volume and Market Share
  • Ferrous Succinate Import Volume and Market Share
  • Leucogen Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • VitamineB4 Import Volume and Market Share
  • Batilol Import Volume and Market Share
  • Inosine Import Volume and Market Share
  • Deoxyribonucleotide Import Volume and Market Share
  • Adrenocortical Hormone Import Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
  • Interferon Treatment Drugs Import Volume and Market Share
  • Imatinib Mesylate Treatment Drugs Import Volume and Market Share
  • Rituximab Treatment Drugs Import Volume and Market Share
  • Pirarubicin Treatment Drugs Import Volume and Market Share
  • Hydroxycampothecin Treatment Drugs Import Volume and Market Share
  • Other Blood Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top